Author: Kalup Alexander
A group that’s buying ads to try to elevate the issue of high drug prices in the midterm elections has identified its latest target: a Democratic congresswoman from Silicon Valley who wants to lead on health care issues.
Major technology companies on Monday announced their commitment to making it easier to share data across the healthcare sector, in a move backed by the White House.
Accountable care organizations were among the key initiatives of the Affordable Care Act, designed to help control soaring Medicare costs. ACOs were expected to save the government nearly $5 billion by 2019, according to the Congressional Budget Office. It hasn’t come anywhere close.
Three months after President Donald Trump announced his blueprint to bring down drug prices, administration officials have begun putting some teeth behind the rhetoric.
On Thursday, August 2, attorneys general from 11 states and the District of Columbia filed suit against the Department of Labor, challenging the Trump administration’s new Association Health Plan (AHP) rule.
For those who make too much money to qualify for health insurance subsidies on the individual market, there may be no Goldilocks moment when shopping for a plan. No choice is just right.
The planned expansion of short-term health plans under a new Trump administration rule unveiled this week is on a crash course with a brick wall in California.
Four years ago, after leaving her career at a medical devices company to raise her children, Ashley Hutton Stanfield became a sales consultant for Arbonne International, a multi-level marketing firm that makes beauty and nutrition products.
Many Republicans assume their party will take another stab at repealing and replacing the Affordable Care Act if the midterm elections go their way, even though GOP candidates aren't making a big deal about it on the campaign trail.
Humana has filed a lawsuit against more than two dozen pharmaceutical companies for conspiring to fix the prices of widely used generic drugs, a scheme that forced the insurer to pay for drugs at artificially inflated prices.